Evidence map›Paper›PMID 21421846›Full record

ArticleJournal of lipid research2011

Complexities of plasma apolipoprotein C-III metabolism.

Frank M Sacks Editorial Board, Chunyu Zheng, Jeffrey S Cohn Editorial Board

Abstract readComment
In one paragraph

Article in Journal of lipid research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Dysfunctional high-density lipoprotein: an updated review.Frontiers in cardiovascular medicine · 2025
    Review
  5. Apolipoprotein-CIIIInternational journal of molecular sciences · 2023
    Article
  6. Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Observational
  7. Review
  8. Review
  9. Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.Arteriosclerosis, thrombosis, and vascular biology · 2019
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Hyperlipoproteinemia type 3: the forgotten phenotype.Current atherosclerosis reports · 2014
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Frank M Sacks Editorial BoardDepartment of Nutrition, Harvard School of Public Health, Boston, MA and Department of Medicine, Harvard Medical School and Brigham & Women's Hospital, Boston, MA. Electronic address: fsacks@hsph.harvard.edu.
Chunyu ZhengDivision of Cardiovascular Medicine, Harvard Medical School and Brigham & Women's Hospital, Boston, MA. Electronic address: czheng1@partners.org.
Jeffrey S Cohn Editorial BoardNutrition and Metabolism Group, Heart Research Institute, Sydney, Australia. Electronic address: cohnj@hri.org.au.

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
NCRR NIH HHS UL1 RR025758
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Apolipoprotein C-IIIApolipoproteins BCase-Control StudiesFemaleHumansKidneyKidney Failure, ChronicLipid MetabolismLipoproteins, HDLLipoproteins, IDLLipoproteins, VLDLLiverMaleMiddle AgedTriglyceridesApolipoprotein C-IIIApolipoproteins BLipoproteins, HDLLipoproteins, IDLLipoproteins, VLDLTriglycerides

Identifiers

PMID21421846
PMCPMC3090227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.